Research Topics
| John P BoehmerSummaryAffiliation: Pennsylvania State University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Device therapy for heart failureJohn P Boehmer
Division of Cardiology, Department of Medicine, Penn State University College of Medicine, Hershey Medical Center, Hershey, Pennsylvania 17033, USA
Am J Cardiol 91:53D-59D. 2003..Further development in this field is expected. The use of devices in HF now has a strong foothold, and the potential exists for substantially greater use of a broad range of devices in the near future...
Adjudication of mortality events in a heart failure-arrhythmia trial by a multiparameter descriptive method: comparison with methods used in heart failure trials and methods used in arrhythmia trialsJohn P Boehmer
Division of Cardiology, The Milton S Hershey Medical Center, The Pennsylvania State College of Medicine, Rm 1512, 500 University Drive, Hershey, PA, 17033, USA
J Interv Card Electrophysiol 23:101-10. 2008..quot; Herein, we describe an adaptation of this descriptive method in a trial of patients with heart failure and arrhythmias...- Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in EuropeWalter E Pae
Heart and Vascular Institute, Milton S Hershey Medical Center, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033 0850, USA
J Heart Lung Transplant 26:219-29. 2007..This sub-study reports infections with the LionHeart and compares these results with historic data from the REMATCH trial, bridge to recovery (BTR) and bridge-to-transplantation (BTT) studies... 
Coronary blood flow responses to physiological stress in humansAfsana Momen
Penn State Heart and Vascular Institute, The Pennsylvania State University College of Medicine, The Milton S Hershey Medical Center, Hershey, Pennsylvania 17033, USA
Am J Physiol Heart Circ Physiol 296:H854-61. 2009..Contrasting responses were noted during systemic hypoxia and hyperoxia where mechanisms independent of autonomic influences appear to dominate the vascular end-organ effects...- Statin use is associated with improved survival in patients with advanced heart failure receiving resynchronization therapyAndrew D Sumner
Division of Cardiology, Lehigh Valley Health Network, Allentown, PA 18103, USA
Congest Heart Fail 15:159-64. 2009..77; CI, 0.61-0.97; P=.03). Statin use is associated with improved survival in patients with advanced chronic HF receiving CRT. No survival benefit was seen in patients receiving statins and optimal pharmacologic therapy without CRT... - Neurologic events with a totally implantable left ventricular assist device: European LionHeart Clinical Utility Baseline Study (CUBS)Walter E Pae
Heart and Vascular Institute, Milton S Hershey Medical Center, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033 0850, USA
J Heart Lung Transplant 26:1-8. 2007..This sub-study was part of the LionHeart European Clinical Utility Baseline Study (CUBS)... - Report of the first U.S. patient successfully supported long term with the LionHeart completely implantable left ventricular assist device systemSanjay M Mehta
The Pennsylvania State University Heart and Vascular Institute/Hershey Medical Center, Hershey, Pennsylvania 17033, USA
ASAIO J 52:e31-2. 2006..The device proved to be reliable during this period of support. Through lifestyle modification, the patient was ultimately deemed an appropriate candidate for heart transplantation and ultimately received successful transplantation... - Changes in the functional status measures of heart failure patients with mechanical assist devicesEvan S Leibner
Heart and Vascular Institute, Milton S Hershey Medical Center, The Pennsylvania State University, College of Medicine, Hershey, PA 17033, USA
ASAIO J 59:117-22. 2013..Although studies have shown an increase in survival and patient's quality of life, exercise capacity as measured by cardiopulmonary exercise testing remains low during cfLVAD support... - Cardiac failure: mechanical support strategiesJohn P Boehmer
Department of Medicine, The Pennsylvania State University College of Medicine, The Penn State Hershey Medical Center, Hershey, PA, USA
Crit Care Med 34:S268-77. 2006..More work is required to best identify populations who will benefit from the therapy and to refine the therapy to reduce associated risks... - A retrospective study of left ventricular assist device-related infectionsBarbara Bentz
Department of Nursing, Penn State Hershey Medical Center, Hershey, PA 17033, USA
J Cardiovasc Manag 15:9-16. 2004..1%, with 31.1% occurring in the pocket and 15.1% in the LVAD itself. There was little if any correlation that existed between time spent in the hospital prior to implantation of an LVAD and the development of device-related infections... - Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trialArthur M Feldman
Department of Medicine, Jefferson Medical College, Philadelphia, PA 19107, USA
Am Heart J 154:861-9. 2007..v.) inotropic support. Chronic parenteral inotropic therapy in UA-HF is costly and requires an indwelling catheter. An effective and safe oral inotrope would have value... - Effect of simulated postprandial hyperglycemia on coronary blood flow in cardiac transplant recipientsPatrick H McNulty
Division of Cardiology, Penn State College of Medicine, Hershey, PA, USA
Am J Physiol Heart Circ Physiol 293:H103-8. 2007..These observations imply that the relationship among hyperglycemia, oxidative stress, and coronary endothelial dysfunction is presumably mediated by mechanisms operating over longer periods of time... - Biventricular pacing in congestive heart failure: a boost toward finer livingJerry C Luck
Pennsylvania State University, Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033-0850, USA
Curr Opin Cardiol 17:96-101. 2002..The acute hemodynamic studies suggest that resynchronization pacing therapy may predict a positive long-term benefit for many patients with congestive heart failure... - Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-studyTeresa De Marco
University of California, San Francisco Medical Center, San Francisco, CA, USA
J Card Fail 14:9-18. 2008.... - Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmiasSteven L Higgins
Scripps Memorial Hospital, La Jolla, California 92038 0028, USA
J Am Coll Cardiol 42:1454-9. 2003..This study was conducted to assess the safety and effectiveness of cardiac resynchronization therapy (CRT) when combined with an implantable cardioverter defibrillator (ICD)... - Initial United States experience with the Paracor HeartNet myocardial constraint device for heart failureCharles T Klodell
University of Florida College of Medicine, Gainesville, Fla, USA
J Thorac Cardiovasc Surg 133:204-9. 2007..myocardial constraint device... - The editor's roundtable: Cardiac resynchronization therapyVincent E Friedewald
Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, Texas, USA
Am J Cardiol 100:1145-52. 2007 - Remote Active Monitoring in Patients with Heart Failure (RAPID-RF): design and rationaleLeslie A Saxon
University of Southern California, Los Angeles, California, USA
J Card Fail 13:241-6. 2007..However, the use and ultimate utility of these combined features for patient management are untested... - Worldwide surgical experience with the Paracor HeartNet cardiac restraint deviceCharles T Klodell
Department of Surgery, Division of Thoracic and Cardiovascular Surgery, University of Florida College of Medicine, Gainesville, Fla 32610, USA
J Thorac Cardiovasc Surg 135:188-95. 2008..We hypothesize that the Paracor HeartNet device (Paracor Medical, Sunnyvale, Calif), placed through a minithoracotomy in patients with severe dilated cardiomyopathy, improves clinical and functional status... - Heart allograft rejection: detection with breath alkanes in low levels (the HARDBALL study)Michael Phillips
Menssana Research, Inc Fort Lee, New Jersey, USA
J Heart Lung Transplant 23:701-8. 2004..Rejection is accompanied by oxidative stress that degrades membrane polyunsaturated fatty acids, evolving alkanes and methylalkanes, which are excreted in the breath as volatile organic compounds (VOCs)... - Prediction of heart transplant rejection with a breath test for markers of oxidative stressMichael Phillips
Menssana Research Inc, Fort Lee, New Jersey, USA
Am J Cardiol 94:1593-4. 2004..98, and 100% specific when the p value was </=0.058; in the intermediate group, the breath test determined the probability of grade 3 rejection and the predictive value of the result...